[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Marker Therapeutics Inc (MRKR)

Marker Therapeutics Inc (MRKR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Marker Therapeutics Inc 2450 Holcombe Blvd TMC Partners Office 1.311 Houston TX 77021 USA

www.markertherapeutics.com Employees: 5 P: 713-400-6400

Sector:

Medical

Description:

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company specializing in the development of innovative peptide and nucleic acid-based immunotherapeutic vaccines for the treatment and eradication of cancer, including metastatic cancer. The company's product pipeline consists of MultiTAA T Cell Therapy, TPIV200 and TPIV100/110 which are in clinical stage. Marker Therapeutics Inc., formerly known as TapImmune Inc., is based in FL, United States.

Key Statistics

Overview:

Market Capitalization, $K 24,509
Enterprise Value, $K 7,469
Shares Outstanding, K 16,673
Float, K 15,723
% Float 94.30%
Short Interest, K 218
Short Float 1.31%
Days to Cover 3.47
Short Volume Ratio 0.39
% of Insider Shareholders 5.70%
% of Institutional Shareholders 22.39%

Financials:

Annual Sales, $ 3,550 K
Annual Net Income, $ -12,160 K
Last Quarter Sales, $ 1,100 K
Last Quarter Net Income, $ -1,700 K
EBIT, $ -12,890 K
EBITDA, $ -12,890 K

Growth:

1-Year Return -7.50%
3-Year Return -66.13%
5-Year Return -94.47%
5-Year Revenue Growth 655.32%
5-Year Earnings Growth 87.05%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.16 on 05/15/26
Next Earnings Date 08/13/26
Earnings Per Share ttm -0.85
EPS Growth vs. Prev Qtr -300.00%
EPS Growth vs. Prev Year 60.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 01/27/23

MRKR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -73.28%
Return-on-Assets % -59.70%
Profit Margin % -342.54%
Debt/Equity 0.00
Price/Sales 6.82
Price/Cash Flow N/A
Price/Book 1.78
Book Value/Share 1.01
Interest Coverage -1.63
60-Month Beta 1.45
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.